{{Rsnum
|rsid=2020955
|Gene=ERCC4
|Chromosome=16
|position=13944802
|Orientation=plus
|GMAF=0.04867
|Gene_s=ERCC4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 6.2 | 42.1 | 51.7
| ASW | 1.8 | 35.7 | 62.5
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 2.8 | 29.4 | 67.9
| MEX | 0.0 | 1.8 | 98.2
| MKK | 3.2 | 22.1 | 74.7
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22768293
|Title=Association between XPF Polymorphisms and Cancer Risk: A Meta-Analysis
|OA=1
}}

{{PMID|16465622|OA=1
}} Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes.

{{PMID|18544627|OA=1
}} Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk.

{{PMID|18711149|OA=1
}} Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.

{{PMID|19270000|OA=1
}} Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway.

{{GET Evidence
|gene=ERCC4
|aa_change=Ser662Pro
|aa_change_short=S662P
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2020955
|overall_frequency_n=729
|overall_frequency_d=10758
|overall_frequency=0.0677635
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=0
|n_articles_annotated=0
|gene_in_genetests=Y
|genetests_reviewed=Y
|nblosum100=3
|autoscore=2
|n_web_uneval=3
}}

{{on chip | Illumina Human 1M}}